| Current Studies |
| Studies Currently Underway in the
Division of Cardiovascular Diseases and Hypertension |
| Status |
| (A)ctive (P)ending (C)losed |
| Study
|
Status |
Sponsor |
P.I. |
Coord.
|
Drug, Intervention
or Device |
| IRB # |
Co-PI |
Tested |
| ABCD-PCI |
P |
Mount Sinai
St. Jude Medical |
Moreyra |
Cargill |
Ambulatory Closure Device
Percutaneous Intervention: a Multi-Center Randomized trial evaluating
the patient satisfaction, safety, and Cost-effectiveness of ambulatory
PCI in the Current Era. |
| AIM-HIGH |
A |
NHLBI & KOS |
Kostis |
Cardona
|
LDL-C lowering
(zocor) & HDL raising (Niaspan); Atherothrombosis Intervention
in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on
Global Health Outcomes |
| |
IRB#5602 |
| ASPREE |
P |
|
Kostis |
|
|
| |
|
| CARE
|
C |
Bracco |
Moreyra |
Cargill |
Visipaque320and
Isovue 370 in Cardiac Angiography in REnally Impaired Patients |
| IRB#0220070137 |
Bankowski |
| CHAMPION |
P |
|
Moreyra |
Cargill |
|
| COMPASS HF |
A |
IRB#0220034523 |
Kostis
Maleki |
Randolph |
Chronicle Offers Management to Patients
with Advanced Signs and Symptoms of Heart Failure |
| CONNECT |
P |
|
Maleki |
Patella |
|
CURRENT
OASIS-7 |
A |
SANOFI-AVENTIS WIRB #20061844
|
Palmeri |
Casazza |
OASIS-7 Clopidogrel optimal
loading dose Usage to Reduce Recurrent EveNTs |
| ELITE |
A |
Cordis |
Moreyra |
Cargill |
Cypher ELITE vs Cypher
Bx VELOCITY
(A prospective, single-Blind, randomized, Multi-center study comparing
the CYPHER ELITE to the CYPHER Bx Velocity Sirolimus-Eluting Stent
systems) |
| FREEDOM |
A |
NHLBI
IRB#0220060151 |
Vagaonescu |
Bankowski |
Future Revascularization
Evaluation in patients with Diabetes Mellitus: Optimal management
of Multivessel disease |
| GeneXpert |
A |
|
Weinstein |
Cardona |
Sepsis |
| HAT
|
C |
NIH (Seattle
ICR)
IRB#4808 |
Kostis |
Cosgrove |
Home Automatic
External Defbrillator Trial:
CPR v AED in AMI |
| Bankowski |
| HF
Action |
C |
NIH (Duke) |
Kostis |
Bankowski
|
Heart Failure
and A Controlled Trial Investigating Outcomes of exercise TraiNing:
Usual care v Exercise in HF |
| IRB#4491 |
|
| IMPROVE
IT |
A |
IRB# 5541
|
Agarwal
|
Cargill |
TIMI - Vytorin
vs. simvastatin in ACS |
| Bankowski |
| ILLUMINATE
|
C |
|
Kostis |
Cosgrove |
Statin plus CETP to raise
HDL |
| INTENSIVE |
A |
SANOFI-AVENTIS |
Vagaonescu |
Cargill |
Study
of Intensive Apidra/Lantus Therapy vs. Sliding Scale Insulin on Infarct
Size in Hyperglycemic Subjects with Anterior STEMI
|
| L.I.A.R. |
A |
IRB# 5643 |
Sharma |
Cosgrove |
Hospital Chart Documentation
Survey |
|
| MADIT-RIT |
P |
|
Maleki |
|
AICD |
MIDAS
|
A |
Dept of Med |
Kostis |
Cosgrove
|
Retrospective record
linkage of administrative records of acute care hospitalization for
cardiovascular disease:
Acute MI, stroke and other CVD |
| IRB# W0633 |
Wilson |
(Myocardial Infarction
Data Acquisition System) |
| OARS |
|
Dept of Medicine |
Wilson, Parikh, Gupta, Fields
|
Cosgrove |
Outpatient Appointment Reminder
Study (TeleVox vs Desk vs NoCall) |
| IRB#0220060341 |
| OSIRIS |
|
|
|
Moreyra |
|
| PILL |
P |
|
|
Kostis |
|
Protein Kinase
C:
Zinc |
A |
|
Korichneva |
|
Regulation of cardiac
tissue PKC by redox stress |
| PROTECT II |
A |
ABIOMED
WIRB |
Moreyra |
Cargill |
IMPELLA r RECOVER r LP
2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing
Non-emergent High Risk PCI |
| Record-AF
|
A |
Sanofi-Aventis
|
Palmeri
|
Casazza
|
Registry
on Cardiac Rhythm Disorders: Assess the control of Atrial Fibrillation
|
|
| SATURN |
P |
AstraZeneca |
Moreyra |
Cargill
Bankowski |
Study
of Coronary Atheroma by InTravascular Ultrasound: Effect of
Rosuvastatin Versus Atorvastatin (SATURN) |
|
| RE-LY |
C |
Boehringer-Ingelheim
|
Kostis |
Cardona |
Randomized
Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran
Etexilate vs. Warfarin in AFib |
|
|
| |
WIRB#0243 |
| TOPCAT |
C |
NIH/NHLBI |
Kostis |
Bankowski
|
Treatment
Of Preserved Cardiac function heart failure with an Aldosterone anTagonist
:Spironolactone in CHF |
| |
|
| |
IRB#0220060231 |
| TRILOGY ACS
|
|
Duke CRI
Daiichi Sankyo & Lilly |
Palmeri |
Casazza |
TRILOGY ACS (TaRgeted
platelet Inhibition to cLarify the Optimal strateGy to medicallY manage
Acute Coronary Syndromes), |
| WARCEF
|
A |
NIH |
Palmeri |
Casazza |
Warfarin,
Asprin |
| IRB #4000 |
| WHIX
|
P |
NIH |
Kostis |
Cosgrove
|
Women's
Health Initiative Extension |
| IRB #1844 |
Lacy |
| |
Wilson |
| WHIMS |
A |
NIH |
Kostis |
Cardona |
Women's Health
Initiative Mental Status |
| |
IRB#2049 |
| XIENCE USA |
P |
Abbott |
Vagaonsecu |
Cargill |
Xience Drug eluting
stent Registry |
|
|
|
|
|
|
